AI-assisted, human-published
05/28/2025 /Funding Events
AusperBio Therapeutics Secures $50 Million in Series B+ Financing
AusperBio Therapeutics successfully concludes an oversubscribed Series B+ funding round of $50 million, reflecting strong investor confidence in the company's vision and progress.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com